TFS Trial Form Support sp. z o.o.
Research and experimental development on biotechnology
Overview
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 840 days for 2020). All were audited by a statutory auditor.
- 2025filed
- 202424/09/2025
- 202331/07/2024
- 202202/02/2024
- 202102/02/2024
- 202002/02/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
If the company has a multi-member management board, the company may be represented and declarations of will may be made on its behalf by the President of the Management Board independently, or by two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Tfs International Clinical Development Services Ab | 12,573 | $169,813.61 | 99% |
Others | 127 | $1,715.29 | 1% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2009-05-27.
26 2370 0008 0000 0000 2104 3005
74 2370 0008 0000 0000 2104 3014
25 2370 0008 0000 0000 2104 3023
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Famicordtx S.A. | $1,365,068.41 | famicordtx.com | ||
| Orphinic Scientific S.A. | $518,429.97 | orphinic.com | ||
| Proper Medical Writing sp. z o.o. | $464,661.64 | propermedicalwriting.com | ||
| Medicofarma Biotech S.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeutics sp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline Biosciences S.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelab sp. z o.o. | $128,365.55 | aicorelab.com | ||
| Modica P.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticals sp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD Pharmaceuticals S.A. | $87,561.70 | wpdpharmaceuticals.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-06-04 | Address change (Ul. Iłżecka 26e, 02-135, Warszawa → Ul. Grójecka 208/2 Piętro, 02-390, Warszawa) | |
| 2015-06-18 | Address change (Ul. Dolna 10/2, 00-774, Warszawa → Ul. Iłżecka 26e, 02-135, Warszawa) | |
| 2015-04-07 | Address change (Iłżecka 26 E, 02-135, Warszawa → Ul. Dolna 10/2, 00-774, Warszawa) | |
| 2015-04-07 | PKD change (Removed: 27 codes) | |
| 2013-11-19 | Share capital increase (5,000.00 PLN → 635,000.00 PLN) |
FAQ
Last updated: 2026-04-17